Gene description for CD109 |
| Gene name |
CD109 molecule |
| Gene symbol |
CD109 |
| Other names/aliases |
CPAMD7 p180 r150 |
| Species |
Homo sapiens |
Experiment description of studies that identified CD109 in Glioblastoma cells |
| 1
|
| Experiment ID | 203 |
| Identified molecule | mrna
|
| Extracellular vesicle type | Microvesicles |
| MISEV | EVs |
| Identification method | Microarray
|
| PubMed ID |
19011622
|
| Organism | Homo sapiens |
| Experiment description | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers |
| Authors | Skog J, Wüer T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO |
| Journal name |
Nat Cell Biol
|
| Publication year | 2008 |
| Sample | Glioblastoma cells |
| Sample name | Glioblastoma cells |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration |
| Flotation density | - |
| Molecules identified in the study | Protein miRNA mRNA |
| Methods used in the study | RT-PCR Antibody array Microarray |
| EV-TRACK |
-
|
|
|
| 2
|
| Experiment ID | 1039 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
27770278
|
| Organism | Homo sapiens |
| Experiment description | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. |
| Authors | Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL. |
| Journal name |
J Neurooncol
|
| Publication year | 2017 |
| Sample | Glioblastoma cells |
| Sample name | A172 |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration Density gradient centrifugation |
| Flotation density | 1.09.1.11 g/mL |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
-
|
|
|
| 3
|
| Experiment ID | 1040 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
27770278
|
| Organism | Homo sapiens |
| Experiment description | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. |
| Authors | Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL. |
| Journal name |
J Neurooncol
|
| Publication year | 2017 |
| Sample | Glioblastoma cells |
| Sample name | LN229 |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration Density gradient centrifugation |
| Flotation density | 1.09.1.11 g/mL |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry Western blotting |
| EV-TRACK |
-
|
|
|
| 4
|
| Experiment ID | 1041 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
27770278
|
| Organism | Homo sapiens |
| Experiment description | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. |
| Authors | Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL. |
| Journal name |
J Neurooncol
|
| Publication year | 2017 |
| Sample | Glioblastoma cells |
| Sample name | U87MG |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration Density gradient centrifugation |
| Flotation density | 1.09.1.11 g/mL |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry Western blotting |
| EV-TRACK |
-
|
|
|
| 5
|
| Experiment ID | 1042 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
27770278
|
| Organism | Homo sapiens |
| Experiment description | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. |
| Authors | Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL. |
| Journal name |
J Neurooncol
|
| Publication year | 2017 |
| Sample | Glioblastoma cells |
| Sample name | U251 |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration Density gradient centrifugation |
| Flotation density | 1.09.1.11 g/mL |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
-
|
|
|
| 6
|
| Experiment ID | 1043 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
27770278
|
| Organism | Homo sapiens |
| Experiment description | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. |
| Authors | Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL. |
| Journal name |
J Neurooncol
|
| Publication year | 2017 |
| Sample | Glioblastoma cells |
| Sample name | T98G |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration Density gradient centrifugation |
| Flotation density | 1.09.1.11 g/mL |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
-
|
|
|
| 7
|
| Experiment ID | 1044 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
27770278
|
| Organism | Homo sapiens |
| Experiment description | Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. |
| Authors | Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL. |
| Journal name |
J Neurooncol
|
| Publication year | 2017 |
| Sample | Glioblastoma cells |
| Sample name | CCF-STTG1 |
| Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration Density gradient centrifugation |
| Flotation density | 1.09.1.11 g/mL |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
-
|
|
|
| 8
|
| Experiment ID | 1274 |
| Identified molecule | protein
|
| Extracellular vesicle type | Microvesicles |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
23807490
|
| Organism | Homo sapiens |
| Experiment description | Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. |
| Authors | Li CC, Eaton SA, Young PE, Lee M, Shuttleworth R, Humphreys DT, Grau GE, Combes V, Bebawy M, Gong J, Brammah S, Buckland ME, Suter CM. |
| Journal name |
RNA Biol.
|
| Publication year | 2013 |
| Sample | Glioblastoma cells |
| Sample name | U251 cells |
| Isolation/purification methods | Differential centrifugation |
| Flotation density | - |
| Molecules identified in the study | Protein miRNA |
| Methods used in the study | Mass spectrometry Microarray |
| EV-TRACK |
EV130098: EV-METRIC:29%
|
|
|